COc1ccc(CN2CC[C@H]3C=CC[C@@H](C(=O)N4CCN(c5ccccc5)CC4)[C@H]3C2=O)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?